Skip to main content
Fig. 7 | Journal of Nanobiotechnology

Fig. 7

From: Immune-regulating strategy against rheumatoid arthritis by inducing tolerogenic dendritic cells with modified zinc peroxide nanoparticles

Fig. 7

In vivo splenic tDCs induction by ZnCM NPs. a Quantitative flow cytometry of in vivo splenic DCs molecules after ZnC and ZnCM NPs treatments. b Observations of in vivo DCs CD80, CD86 expressions in spleen and c CD4+ T cells expression in ankle synovium after various NPs treatments. (blue: DAPI; red: CD11+ DCs; green: CD80/CD86 DCs; yellow: co-localization of CD11+ and CD80/CD86). ** indicated the significant difference of p ≤ 0.05 compared with Vehicle, # indicated the significant difference of p ≤ 0.05 compared with Ctrl

Back to article page